Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat with Pemetrexed-Cisplatin in Mesothelioma
NCT01353482Phase 2Withdrawn
- Sponsor
- University College London
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
01
Overview
A Phase 2 trial of vorinostat in malignant pleural mesothelioma (MPM), sponsored by University College London. Status: withdrawn.
02
Drugs
vorinostat
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT01353482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01353482.